Related Experiment Video
Updated: May 28, 2026

2-Vessel Occlusion/Hypotension: A Rat Model of Global Brain Ischemia
Published on: June 22, 2013
Emerging mechanisms of disrupted cellular signaling in brain ischemia
1Toronto Western Research Institute, University Health Network, Toronto, Ontario, Canada. miketym2@rogers.com
Abstract:
Recent findings have provided insights into pathogenic mechanism(s) that may complement and add to the traditional glutamatergic mechanisms to which ischemic brain injury is ascribed. The discovery of mechanisms leading to ionic imbalance and signaling cascades that mediate cross-talk between redundant pathways of cell death, as well as mechanisms that operate downstream of, upstream of and in parallel with excitotoxicity, has spurred new research into therapeutics ranging from proof of concept in animals to human clinical trials. This Perspective presents an integrated consideration of new molecular pathogenic mechanisms underlying ischemic damage in the brain, and how our combined knowledge of these mechanisms and our existing knowledge of excitotoxicity may establish new targets for therapy, by allowing clearer boundaries on what might be expected of a given intervention, and may yield advances that will benefit patients.
Insights
New research reveals molecular mechanisms beyond traditional excitotoxicity in ischemic brain injury. Understanding these pathways offers novel therapeutic targets for stroke, potentially improving patient outcomes.
Area of Science:
- Neuroscience
- Pathology
- Biochemistry
Background:
- Ischemic brain injury is traditionally linked to glutamatergic excitotoxicity.
- Emerging evidence suggests additional pathogenic mechanisms contribute to neuronal damage.
Purpose of the Study:
- To present an integrated view of novel molecular mechanisms in ischemic brain damage.
- To explore how these mechanisms, combined with excitotoxicity knowledge, can inform new therapeutic strategies.
Main Methods:
- Review and synthesis of recent findings on molecular pathogenesis of ischemic brain injury.
- Analysis of signaling cascades, ionic imbalance, and cell death pathways.
- Integration of new data with existing understanding of excitotoxicity.
Main Results:
- Identification of mechanisms operating parallel, upstream, and downstream of excitotoxicity.
- Discovery of pathways involving ionic imbalance and cross-talk between cell death routes.
- Evidence supporting new therapeutic targets from animal models to human trials.
Conclusions:
- New molecular mechanisms complement traditional excitotoxicity in ischemic brain injury.
- Integrated knowledge of these pathways can define clearer therapeutic intervention boundaries.
- Advances in understanding these mechanisms hold promise for patient benefit.
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction
Cellular Injury I: Introduction
Cerebral Edema ll: Pathophysiology
Cellular Injury IV: Necrosis
Transient Ischemic Attack l: Introduction

